Evidence map›Paper›PMID 40786194›Full record

ArticleIranian journal of medical sciences2025

Joint Modeling of Longitudinal Visual Field Changes and Time to Detect Progression in Glaucoma Patients: A Secondary Data Analysis.

Samaneh Sabouri, Elham Haem, Masoumeh Masoumpour, Hans G Lemij, Koenraad A Vermeer, Siamak Yousefi, Saeedeh Pourahmad

Abstract read
In one paragraph

Article in Iranian journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Samaneh SabouriDepartment of Biostatistics, School of Health, Mashhad University of Medical Sciences, Mashhad, Iran.
Elham HaemDepartment of Biostatistics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Masoumeh MasoumpourDepartment of Ophthalmology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Hans G LemijRotterdam Ophthalmic Institute, the Rotterdam Eye Hospital, Rotterdam, Netherlands.
Koenraad A VermeerRotterdam Ophthalmic Institute, the Rotterdam Eye Hospital, Rotterdam, Netherlands.
Siamak YousefiDepartment of Ophthalmology, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Saeedeh PourahmadDepartment of Biostatistics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Glaucoma causes irreversible damage to the optic nerve and can lead to blindness if it is not treated appropriately. Evaluation of longitudinal changes in the visual field (VF) and detecting progression in a timely manner are critical for effective disease management. This study aimed to identify factors associated with VF impairment and disease progression using a Bayesian joint model. Methods: A total of 129 glaucoma patients (228 eyes) were recruited from an ongoing cohort study initiated in 1998 at the Rotterdam Eye Hospital in the Netherlands. Standard Automated Perimetry (SAP) was performed for each patient at regular 6-month follow-up intervals. Covariates included sex, age at baseline, mean intraocular pressure (IOP), and disease severity. A Bayesian joint model was employed, integrating a linear mixed effects model (LMM) for longitudinal mean deviation (MD) values and a Cox proportional hazards model for progression time. The statistical analyses were conducted using R software and the 'JMbayes2' package. Results: Progression was observed in 33.8% of eyes. A significant association was found between MD changes and progression risk (α=-0.39, P<0.001). Older age (P=0.01), early-stage disease (P<0.001), and higher mean IOP (P<0.001) were associated with an increased risk of progression. Conclusion: Considering longitudinal MD changes, age at baseline, mean IOP, and disease severity were significantly associated with the time to progression detection. Sex was not found to be a significant factor in glaucoma progression.

Indexed as

GlaucomaVisual FieldsAgedBayes TheoremDisease ProgressionFemaleHumansIntraocular PressureMaleMiddle AgedNetherlandsSecondary Data AnalysisVisual Field TestsDisease progressionGlaucomaJoint modelLongitudinal studiesSurvival analysis

Identifiers

PMID40786194
PMCPMC12334790

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.